Curcumin combining with si-MALAT1 inhibits the invasion and migration of colon cancer SW480 cells

Curcumin combining with si-MALAT1 inhibits the invasion and migration of colon cancer SW480 cells

To study the effect of small interfering RNA targeting metastasis-associated lung adenocarcinoma transcript1 (si-MALAT1) combining with curcumin on the invasion and migration abilities of human colon cancer SW480 cells, and to explore the involved molecular mechanism. The recombinant lentiviral vect...

Full description

Bibliographic Details
Main Authors:	Dai Wei, LI Shi Yun, Xiao Dejun, Liu Cong, Jin-Hua He, Lin Yan
Format:	Article
Language:	English
Published:	Universidade de São Paulo
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Curcumin/ pharmacology LncRNA-MALAT1 RNA Small Interfering/ drug effects Colon cancer Invasion Migration Colonic Neoplasms/ prevention & control Colonic Neoplasms/ drug therapy Neoplasm Invasiveness/ prevention & control Cell Migration Inhibition/ drug effects
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502019000100512&lng=en&tlng=en

Similar Items

olymorphism and Expression of Drug resistance Genes in Colorectal Cancer Patients Given Adjuvant Folfox-4 Chemotheraphy
by: Mirakhrli, Mogjan
Published: (2011)

Increased Level of Long Non-Coding RNA MALAT1 Is a Common Feature of Amoeboid Invasion
by: Ladislav Merta, et al.
Published: (2020-05-01)

Two Synchronous Pseudoinvasive Adenomas: Twice the Caution?
by: Jaime Pereira Rodrigues, et al.
Published: (2016-11-01)

Evaluation of Curcumin Nano-micelle on Proliferation and Apoptosis of HT29 and Hct116 Colon Cancer Cell Lines
by: Hamidreza Mohammadi, et al.
Published: (2022-01-01)

Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer
by: Ana Luiza Normanha Ribeiro de Almeida, et al.
Published: (2016-01-01)

Colon Capsule Endoscopy: Indications, Findings, and Complications – Data from a Prospective German Colon Capsule Registry Trial (DEKOR)
by: Johannes Hausmann, et al.
Published: (2021-01-01)

Antioxidant and phytochemical properties and in vitro cancer chemopreventive effects of averrhoa bilimbi l. extract on human breast and cervical adenocarcinoma
by: Yan, See Wan
Published: (2012)

Comparative evaluation of oncologic outcomes in colon cancer
by: Mário Vinícius Angelete Alvarez Bernardes, et al.
Published: (2016-01-01)

Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis [Retraction]
by: Luan C, et al.
Published: (2023-08-01)

Potential of phytic acid extracted from rice bran as antioxidative compound and anti-proliferation agent in colon cancer cell line
by: Mohamed Shakrin, Norashareena
Published: (2013)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
by: Hyun Jin Bang, et al.
Published: (2022-05-01)

Mining the Proteome of subsp. ATCC 25586 for Potential Therapeutics Discovery: An Approach
by: Abdul Musaweer Habib, et al.
Published: (2016-12-01)

Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study
by: Omar F. Khan, et al.
Published: (2019-02-01)

The Long Noncoding RNA LOC441461 (STX17-AS1) Modulates Colorectal Cancer Cell Growth and Motility
by: Jui-Ho Wang, et al.
Published: (2020-10-01)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01)

Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma
by: Hang-Lung Chang, et al.
Published: (2020-04-01)

Drug Response Associated With and Prognostic lncRNAs Mediated by DNA Methylation and Transcription Factors in Colon Cancer
by: Jiayu Zhang, et al.
Published: (2020-11-01)

Cáncer de colon recurrente: intervalo libre de enfermedad y tratamiento adyuvante Recurrent colon cancer: disease free interval and adjuvant treatment
by: Zenén Rodríguez Fernández, et al.
Published: (2009-12-01)

Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor
by: Man Fung Ho, et al.
Published: (2023-09-01)

Bowel Preparation for Surveillance Colonoscopy After Colorectal Resection: A New Perspective
by: Donghyoun Lee, et al.
Published: (2019-06-01)

A Case of Cecal Endometriosis Presenting as Subepithelial Tumor
by: Min Sik Hwang, et al.
Published: (2016-10-01)

Clinico-pathological and oncological differences between right and left-sided colon cancer (stages I-III): analysis of 950 cases
by: Javier-A. Cienfuegos, et al.

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
by: Xiaomei Tang, et al.
Published: (2022-01-01)

Morphology, Histopathology, and Anatomical Distribution of Sporadic Colorectal Polyps in Chinese Patients
by: Chunpeng Zhu, et al.
Published: (2023-01-01)

New Insights into Long Non-Coding RNA <i>MALAT1</i> in Cancer and Metastasis
by: Yutong Sun, et al.
Published: (2019-02-01)

Effect of LncRNA-MALAT1 on mineralization of dental pulp cells in a high-glucose microenvironment
by: Xinzhu Li, et al.
Published: (2022-08-01)

Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down‐regulation of lncRNA MALAT1
by: Wei Zhang, et al.
Published: (2022-06-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
by: Jian Luo, et al.
Published: (2022-08-01)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
by: Yilin Lin, et al.
Published: (2020-04-01)

A Review of Current Concepts In Cancer Chemotherapy
by: Laurie F. Smaldone, et al.
Published: (2023-08-01)

Downregulation of long noncoding RNA HCP5/miR-216a-5p/ZEB1 axis inhibits the malignant biological function of laryngeal squamous cell carcinoma cells
by: Sen Zhang, et al.
Published: (2022-09-01)

Anti‐inflammatory mechanisms in cancer research: Characterization of a distinct M2‐like macrophage model derived from the THP‐1 cell line
by: Katharina M. Scheurlen, et al.
Published: (2023-12-01)

POLYMORPHISM OF THE COX-2 GENE AND SUSCEPTIBILITY TO COLON AND RECTAL CANCER
by: Denise Camilios COSSIOLO, et al.
Published: (2017-06-01)

The Anticancer Effect of Arctium lappa and Glycyrrhiza glabra on HT-29 Colon Cancer and MCF-7 Breast Cancer Cell Lines
by: Shiva Alizadeh Nazmi, et al.
Published: (2018-04-01)

Diabetes Mellitus and Site-specific Colorectal Cancer Risk in Korea: A Case-control Study
by: Hyeongtaek Woo, et al.
Published: (2016-01-01)

MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis
by: Mohamed Ali Hussein, et al.
Published: (2024-01-01)

MALAT1-regulated gene expression profiling in lung cancer cell lines
by: Jungwook Roh, et al.
Published: (2023-09-01)

Therapeutic impact of colon capsule endoscopy with PillCam™ COLON 2 after incomplete standard colonoscopy: a Spanish multicenter study
by: Óscar Nogales, et al.

Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer
by: Zhao K, et al.
Published: (2018-11-01)